NUR-SULTAN. KAZINFORM – Clinical trials of the Kazakh QazCovid-in vaccine opposed to the COVID-19 virus evolved through the Scientific Research Institute for Biosafety Issues have started in Kazakhstan, Kazinform cites the Telegram channel of the Ministry of Education and Science.
He is that adult volunteers between the ages of 18 and 50 will be involved in clinical trials. Phase 1 trials will outline vaccine protection in 44 COVID-19-free and antibody-free volunteers. The moment phase is described to evaluate immunogenicity with the participation of 22 volunteers.
A total of 688 programs were submitted through citizens to participate in clinical trials.
Vaccine trials are said to be conducted at the Phthisiopulmonology National Science Center and the Clinical Medicine and Research Center of the Ministry of Health.